期刊名称 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY EUR J CLIN PHARMACOL |
---|---|
期刊ISSN | 0031-6970 |
期刊官方网站 | http://www.springer.com/biomed/pharmaceutical+science/journal/228 |
是否OA | 否 |
出版商 | Springer Verlag |
出版周期 | Monthly |
始发年份 | 1970 |
年文章数 | 169 |
最新影响因子 | 2.4(2023) scijournal影响因子 greensci影响因子 |
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学3区 | PHARMACOLOGY & PHARMACY 药学3区 | 否 | 否 |
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 2.71 | 1.044 | 1.225 |
Medicine Pharmacology (medical) |
67 / 232 | 71% |
|||
Pharmacology, Toxicology and Pharmaceutics Pharmacology |
102 / 300 | 66% |
自引率 | 4.80% |
---|---|
H-index | 92 |
SCI收录状况 |
Science Citation Index Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PMC) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0031-6970%5BISSN%5D |
期刊投稿网址 | https://mc.manuscriptcentral.com/ejcp?PROXY_TO_PAGE_NAME=&PRE_ACTION=&DISPLAY=&CURRENT_PAGE=LOGIN&SAVE_MS_DETAILS_VALIDATE_FL=&SAVE_MS_DETAILS_FL=&NEX |
---|---|
收稿范围 |
Straightforward phase I pharmacokinetic or pharmacodynamic studies as parts of new drug development will only be considered for publication if the paper involves
Straightforward descriptive data in drug utilization will only be considered if more than one geographical area is studied and if a scientific hypothesis is tested or an intervention carried out. Descriptive data in drug utilization can however be quite useful in a more local setting. Again, if conceptually new methods, analysis, or ways of reasoning are involved, this would elicit greater interest from the international scientific community. In such a case, we would welcome submission to the EJCP and evaluate the paper according to standard procedures. The Journal also accepts review articles on various topics related to drug action in man. Debate on controversial issues is also encouraged, usually in the form of a letter to the editor that comments on a paper published in the Journal. Case reports on new findings or a new understanding of a mechanism of action should usually also be submitted in the form of a letter to the editor. |
收录体裁 | |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |
|